Insight

Jame Abraham/my.clevelandclinic.org

Jun 24, 2025, 08:59

Jame Abraham: ASCO Guideline Clinical Insights – Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

Jame Abraham, Chairman and Professor of the Department of Hematology and Medical Oncology at the Cleveland Clinic, shared a post on LinkedIn:

“Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights.

In 2025, ASCO published a guideline update on the use of sentinel lymph node biopsy (SLNB) in patients with early-stage breast cancer (stages I and II) treated with up-front breast-conserving surgery.

This companion article addresses some of the questions that clinicians may face as they implement the recommendations into clinical practice.”

Jame Abraham

Title: Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights

Journal: JCO

Authors: Ko Un Park, Raymond B. Mailhot Vega, Samantha Shams, Jeffrey Hawley, Mark R. Somerfield, Alastair M. Thompson, Mylin A. Torres

Read the full article.

Jame Abraham

More posts featuring Jame Abraham on OncoDaily.

Alastair M. Thompson ASCO Breast Cancer cancer Cleveland Clinic Jame Abraham Jeffrey Hawley Ko Un Park lymph node biopsy Mark R. Somerfield Mylin A. Torres OncoDaily Oncology Raymond B. Mailhot Vega Samantha Shams

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself